Evidence map›Paper›PMID 23040813›Full record

ReviewNeuron2012

The fibroblast growth factor family: neuromodulation of affective behavior.

Cortney A Turner, Stanley J Watson, Huda Akil

Open access · bronzeAbstract readReview
In one paragraph

Review in Neuron, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 1 synthesis or guideline pooled it, 152 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The neurobiology of stress: Vulnerability, resilience, and major depression.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  12. Article
  13. Serum Growth Factors in Schizophrenia Patients.Current issues in molecular biology · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Serum Klotho and FGF23 Levels in Patients with Schizophrenia.Psychiatry and clinical psychopharmacology · 2022
    Article
  18. Review
  19. Article
  20. Review

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Cortney A TurnerMolecular and Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, MI 48109, USA. caturner@umich.edu
Stanley J Watson
Huda Akil
University of Michigan–Ann Arbor · US

Funding

MICHIGAN INSTITUTE FOR CLINICAL AND HEALTH RESEARCH (MICHR) (UL1): (BPCA)UL1RR024986 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHANLEY, THOMAS P. · 2007 to 2011
$51.2M
Project 5: High-Throughput Analysis of Gene RegulationP50MH060398 · NIMH · UNIVERSITY OF CALIFORNIA-IRVINE · PI BUNNEY, WILLIAM E · 1999 to 2008
$12.7M
TISSUE SPECIFIC /INDUCIBLE REGULATION RECEPTORS /TRANSGEP01MH042251 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WATSON, STANLEY J · 1987 to 2006
$8.3M
POSTDOCTORAL TRAINING IN THE BIOLOGY OF DRUG ABUSET32DA007268 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TRAYNOR, JOHN R. · 1991 to 2021
$6.7M
FOREBRAIN OVEREXPRESSION OF A STRESS-RELATED GENEP01DA021633 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI AKIL, HUDA · 2007 to 2011
$6.2M
Stress/Vulnerability to Drug Abuse: Neural CorrelatesR01DA013386 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI AKIL, HUDA · 2001 to 2005
$1.9M
NCRR NIH HHS UL1 RR024986NCRR NIH HHS UL1RR024986NIDA NIH HHS P01 DA021633NIDA NIH HHS R01 DA013386NIDA NIH HHS T32 DA007268NIMH NIH HHS P01 MH042251NIMH NIH HHS P50 MH060398NIMH NIH HHS P50 MH60398
6 · The paper itself

Abstract

In this review, we propose a broader view of the role of the fibroblast growth factor (FGF) family in modulating brain function. We suggest that some of the FGF ligands together with the FGF receptors are altered in individuals with affective disorder and modulate emotionality in animal models. Thus, we propose that members of the FGF family may be genetic predisposing factors for anxiety, depression, or substance abuse; that they play a key organizing role during early development but continue to play a central role in neuroplasticity in adulthood; and that they work not only over extended time frames, but also via rapid signaling mechanisms, allowing them to exert an "on-line" influence on behavior. Therefore, the FGF family appears to be a prototype of "switch genes" that are endowed with organizational and modulatory properties across the lifespan, and that may represent molecular candidates as biomarkers and treatment targets for affective and addictive disorders.

Indexed as

AnimalsBrainFibroblast Growth FactorsGenetic Predisposition to DiseaseHumansMood DisordersNeurotransmitter AgentsFibroblast Growth FactorsNeurotransmitter Agents

Identifiers

PMID23040813
PMCPMC3476848
OpenAlexW2063710526

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.